Related Experiment Video
Updated: Jul 30, 2026

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Sprouty genes are expressed in osteoblasts and inhibit fibroblast growth factor-mediated osteoblast responses
X Yang1, J B Webster, D Kovalenko
1Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA.
Abstract:
Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) are major regulators of skeletal growth and development. Signal transduction via FGFRs is complex and mediates proliferation, differentiation, or migration depending upon the cellular context. Members of the Spry gene family antagonize the FGFR signal transduction pathway and inhibit lung morphogenesis, angiogenesis, and chondrogenesis. We examined the expression of Spry2 in the osteoblastic MC3T3-E1 cell line. MC3T3-E1 cells express Spry2 in response to FGF1 stimulation. Treatment of MC3T3-E1 cells with FGF1 results in the expression of Spry2 in a manner consistent with an early response gene. Pharmacological inhibitors of mitogen-activated protein kinase activation inhibit FGF1-induced expression of Spry2 mRNA. Transient overexpression of Spry2 in MC3T3-E1 resulted in decreased FGF1-mediated extracellular signal-regulated kinase phosphorylation and FGF1-stimulated osteopontin promoter activity. Furthermore, we show that Spry2 interacts with Raf-1 in a glutathione-S-transferase pulldown assay and that this interaction may involve multiple sites. Finally, Spry2 expression precedes the onset of the expression of osteoblast differentiation markers in an in vitro assay of primary osteoblast differentiation. Taken together, these results indicate that Spry2 expression is an early response to stimulation by FGF1 in MC3T3-E1 cells and acts as a feedback inhibitor of FGF1-induced osteoblast responses, possibly through interaction with Raf1.
Insights
Fibroblast Growth Factor 1 (FGF1) stimulates Spry2 expression in osteoblasts, acting as an early response. Spry2 then inhibits FGF1-driven osteoblast differentiation, potentially via Raf-1 interaction.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Fibroblast growth factors (FGFs) and their receptors (FGFRs) are critical regulators of skeletal development.
- FGFR signaling pathways influence cell proliferation, differentiation, and migration.
- Spry gene family members antagonize FGFR signaling, impacting various developmental processes.
Purpose of the Study:
- To investigate the role of Spry2 in osteoblast differentiation.
- To determine the response of Spry2 expression to FGF1 stimulation in MC3T3-E1 cells.
- To elucidate the inhibitory mechanism of Spry2 on FGF1-induced osteoblast responses.
Main Methods:
- Examined Spry2 expression in MC3T3-E1 cells following FGF1 stimulation.
- Utilized pharmacological inhibitors of mitogen-activated protein kinase (MAPK) pathway.
- Performed transient overexpression of Spry2 and analyzed downstream signaling (ERK phosphorylation, osteopontin promoter activity).
- Investigated Spry2 interaction with Raf-1 using glutathione-S-transferase pulldown assays.
- Assessed Spry2 expression relative to osteoblast differentiation markers in primary osteoblasts.
Main Results:
- FGF1 stimulation induced Spry2 expression in MC3T3-E1 cells as an early response gene.
- MAPK pathway inhibitors reduced FGF1-induced Spry2 mRNA expression.
- Spry2 overexpression decreased FGF1-mediated ERK phosphorylation and osteopontin promoter activity.
- Spry2 was shown to interact with Raf-1.
- Spry2 expression preceded the onset of differentiation marker expression in primary osteoblasts.
Conclusions:
- Spry2 is an early response gene to FGF1 in osteoblasts.
- Spry2 acts as a feedback inhibitor of FGF1-induced osteoblast responses.
- Spry2 may inhibit FGF1 signaling through interaction with Raf-1, modulating osteoblast differentiation.
Related Concept Videos
Growth of Cartilage and Bone Tissue
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Endochondral Ossification
Gene Regulation During Sporulation

